Fate Therapeutics is a clinical-stage biopharmaceutical company focused on developing iPSC-derived cellular immunotherapies for cancer and autoimmune diseases. The company leverages its proprietary iPSC platform to create and manufacture off-the-shelf, multiplexed-engineered NK and T-cell products.
